Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 15, 2005
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Heparin, Low-Molecular-Weight (MeSH)
- Humans (MeSH)
- Immunology (Science Metrix)
- Orthopedics (MeSH)
- Risk Factors (MeSH)
- Thrombocytopenia (MeSH)
- Thrombosis (MeSH)
published in
- Blood Journal